Drug Type Monoclonal antibody |
Synonyms VHB837, VHB937 |
Target |
Mechanism TREM2 stimulants(Triggering receptor expressed on myeloid cells 2 stimulants) |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Phase 2 | US | 17 Oct 2024 |